PL116944B1 - Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles,9b-geksagidro-1h-pirido/4,3-b/indolov - Google Patents

Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles,9b-geksagidro-1h-pirido/4,3-b/indolov Download PDF

Info

Publication number
PL116944B1
PL116944B1 PL1978215923A PL21592378A PL116944B1 PL 116944 B1 PL116944 B1 PL 116944B1 PL 1978215923 A PL1978215923 A PL 1978215923A PL 21592378 A PL21592378 A PL 21592378A PL 116944 B1 PL116944 B1 PL 116944B1
Authority
PL
Poland
Prior art keywords
formula
trans
pyrido
compounds
indoles
Prior art date
Application number
PL1978215923A
Other languages
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL116944B1 publication Critical patent/PL116944B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Przedmiotem wynalazku jest sposób wytwarza¬ nia nowych 4a,9b-trans-5-arylo-2,3,4,4a,5,9b-szescio- wodoro-lH-pirydo-[4,3-b]indoIi o wzorze 1, w któ¬ rym X i Y oznaczaja atomy fluoru, stanowiacych zwiazki wyjsciowe w syntezie nowych podstawio¬ nych w pozycji 2 4a,9ib-trans-5-arylo-2,3,4,4a,5,9b- -szesciowodoro-lH pirydo[4,3-b]indo!i (szesciowodo- ro-y-karbolin) i dopuszczalnych w farmacji soli tych zwiazków, wykazujacych dzialanie uspokajajace.Po wprowadzeniu do psychoterapii we wczesnych latach 1950 rezerpiny i chloropromazyny, znaczny wysilek skierowano na poszukiwanie innych czyn¬ ników uspokajajacych, o lepszym profilu biologicz¬ nym. Znaleziono kilka zwiazków czynnych w grupie pirydo[4,3-b}indoli, zwanych y-karbolinami.W opisie patentowym St. Zjedn. Ameryki nr 3 687 961 przedstawiono 8-fluoro-2-[3-/4-fluorofe- nyloanilino/propylo]-l,2,3,4-czterowodoro-y-kar- boline jako uzyteczny czynnik uspokajajacy dla zwierzat cieplokrwistych. W opisie patentowym St.Zjedn. Ameryki nr 3 755 584 stwierdzono, ze podob¬ na czynnosc wykazuja zwiazki pokrewne, z ato¬ mami fluoru, w pozycjach 6 lub 8. a zwlaszcza zwiazki podstawione w pozycji 2 rodnikiem feny- loalkilowym z podstawnikiem para pierscienia fe nylowego.W opisie patentowym St. Zjedn. Ameryki nr 3 983 239 przedstawiono szesciowodoro-y-karboliny o wzorze 8, w którym R1 oznacza rodnik metylo¬ wy lub etylowy, a R2 oznacza atom wodoru, rod¬ nik metylowy lub rodnik etylowy. W opisie nie wspomina sie o stereochemicznej wspólzaleznosci atomów wodoru zwiazanych z atomami wegla w pozycjach 4a i 9b. Mozna jednak oczekiwac, ze a a"omy te sa we wzajemnym polozeniu cis, ponie¬ waz zwiazki otrzymano przez katalityczne uwodor¬ nienie odpowiednich 1,2,3,4-czterowodoro-y-karbo- lin w obecnosci platyny, a jak wiadomo, atomy wodoru wprowadzone tym sposobem do podwój- 10 nego wiazania wegiel-wegiel znajduja sie we wza¬ jemnym polozeniu cis. Zwiazki o wzorze 8 zastrze¬ zono jako neuroleptyki, uzyteczne w leczeniu schi¬ zofrenii.W opisie patentowym St. Zjedn. Ameryki nr U 3 991 199 przedstawiono szesciowodoropirydo[4,3-b] indole, uzyteczne jako srodki przeciwbólowe i psy¬ chotropowe. Niektóre z nich sa interesujace jako srodki uspokajajace, natomiast inne jako czynniki zwalniajace napiecie miesni. Wie-e z nich wykazuje 20 czynnosc hopotensyjna. W opisanych zwiazkach atomy wodoru przy atomach wegla w pozycjach 4a i 9b we wzajemnym polozeniu trans. Zwiazki przedstawia ogólny wzór 9, w którym gdy Ya oz¬ nacza -H, Xa oznacza -H, -Cl, -Br, -CH3, -III rz. 25 G4H9 lub -OCH3, a gdy Ya=-OF3, to Xa=-H; a Ra oznacza atom wodoru lub rodnik 2-/3-chloro/ /butenylowy, 2-bromoallilowy, benzylowy, benzy¬ lowy podstawiony rodnikiem metylowym, grupa metoksylowa lub atomem chloru, fenyloetylowy, 30 3-fenylopropylowy, 3-fenylopropylowy, podstawio- 116 944116 644 3 ny w pierscieniu atomem chloru lub bromu lub grupa metoksylowa, furfurylowy, 2-tienylowy, Cj-Cs-alkilowy, C8-C6-alkenylowy, Cs-C5-alkinylo- wy, cynamylowy, cynamylówy podstawiony w pier¬ scieniu atomem chloru, atomem bromu lub grupa metoksylowa, 2-/3-fenylo/propynylowy, C8-C7-cy- kloalkilowy, C4-C8-cykloalkilometylowy, /metylocy- klopropylo/metylowy, /cis-2,3-dwumetylocyklopro- pylo/metylowy, C6-C7-cykloalkenylometyloWy, C6- -C8-cykloalkinylometylowy, [l-/2,3-dwumetylocyklo- propen-2/ylo]-metylowy egzo-7-norkarylometylo- wy, [7-/cis-lj6-dwumetylo-endb*3*noTkaTen7ylo] me¬ tylowy, l-/4-mstylóbicyklo[2.2.2]oktylo/rhetylowy l-/4-metylobicyklo]2.2.2[okten-2-ylo/-metylowy, 5-/bicyklo[2.2.2.]lrepten-^-ylo/metylowy, 1-adamah* tylometylowy lub 2-adamantylometylowy.W belgijskim opisie patentowym nr 845 368 (Derwent No. 00043Y) przedstawiono 5-fenylosze^ sciowódoro-y-karboliny, ewentualnie podstawione w pozycjach 2 i 4 rodnikami metylowymi lub ety¬ lowymi, a w pozycji 3 rodnikiem alkilowym o 1-3 atomach wegla, rodnikiem allilowym lub rodnikiem propargilowym. Zwiazki te sa uzyteczne jako czyn¬ niki antydepresyjne.W ogloszeniowym opisie patentowym RFN nr 2 631836 (Derwent No 0988Y) opisano struktural¬ nie zblizone osmiowodoropirydo[4',3':2,3] indolo [1,7-ab] [l]benzazepiny, które mozna przedstawic wzorem 9, w którym Ya oznacza mostek etyterló* wy miedzy dwdffla pier§ai6fiiami benzenowymi, X* oznacza atom wodoru, a Ra oznacza grupe -CH2CH2COCH8 lub -CH2CH2COC6H5. Zwiazki te sa uzyteczne jako czynniki przeciwbólowe i uspo¬ kajajace.W Opisie patentowym 5t; Zjedn. Ameryki nr 4 001 fttil przedstawiono dzialajace uspokajajaco 5*arylO*I,2jM*e^teroWodofo*^karT3olin^ o wzorze 1 oztiadliaja atom wodoru lub fluoru, a Rb oznacza rodnik metylowy, grupe, ó WzOfze ^/CH^M-C^Z lUb */Gtt8/nl-CH=CH- -C6H4Z, w których to wzorach n jest równe 3 lub 4, m jdst równe 2 lub 3, M oznacza -CO- lub -CH/OH/-, a Z ozn&eza wodór, fluor lub grupe me¬ toksylowa, Nieoezdkiwafttó stWtefdZóno, ze zttacznie wy2s*a eiynnosc uspokajaja niz l^^^-CKt^towodoi-o^- karboliny maja trans-2,3,4,4a,5,9b-szesciowddóró- -lH-#ifydO[4,3-b]i*ldole o wiórze ógólftym 3, w którym X i Y &mettjA atomy fluofu, n ózhaetó liczbe 3 lub 4, M OZnasza grtipc o WZófzg 4 lub 5, a Z oznacza atom wodoru, fluoru lub gfujfc fflcto- ksylowa oraz dopuszczalne w farmacji sole tych zwiazków albo o wzorze Ó, w Którym X i Y fflafó wyl«j podane znficzenie, m oznacza HOZbe 2 Ittb 3, a z oznacza atom fluoru lub gfupe metoksylowa otfaz dopuszczalne w farmacji sole tych zwiazków, w$ wzajamnyin polozeniu trans s$ w iym zwkjz* kach atomy wodoru przy at<*ma Stwierdzono, ze zwózki o wzorze 3, w którym X i Y ózriaczaft atomy fluoru wykazuja nieocze¬ kiwane, korzystne dzialania przy niskiej dawce, utrzymujace sie na tym samym poziomic aktywno¬ sci pitst do najmniej 24 godziny. 2wi4zki o wzorze l, wytwarzane sposobem We¬ dlug wynalazku sa zwiazkami wyjsciowymi do wytwarzania zwiazków ó WzófzG 3, stanowiacych niespodziewanie aktywne zwiazki finalne.Sposób wedlug wynalazku Wytwarzania zwiaz¬ ków o wzorze 1, w którym X i Y oznaczaja ato- s my fludru, polega na tym, ze na 4a,9b-trans-2,3,4, 4a,5,9b-szesciowOdoro-lH-pirydo[4,3-b]-indol o wzo¬ rze 2, w którym Xi Y maja wyiaj podane zna¬ czenie, a R2 oznacza rodnik beniyloWy, dziala sie wodorem w obecnosci palladu na WgglU. io Reakcje zazwyczaj przeprowadza sie na chlorowo¬ dorku zwiazku o wzorze 2, w 50-100, korzystnie 00—75°Cj pod cisnieniem wodoru, 1,4—7 kG/cm2, w obecnosci obojetnego w reakcji rozpuszczalnika, np. metanolu, etanolu, izopropanolu, octanu etylu ii lUb mieszanin tych rozpuszczalników z „ woda. Po zakonczeniu pochlaniania wodoru óds^czU lici kata¬ lizator, a zwiazek o wzorze 1 wytraca w postaci ehldroWodorku* dodaniem np. eteru etyioWego, ben¬ zenu lub heksanu. Alternatywnie mozna zwiazek w o wzorze 1 wyodrebnic w postaci wolnej zasady, odparowujac przesacz i reakcji odbenzylowania do sucha i poddajac pozostalosc rozdzialowi miedzy wodny roztwÓi* wodorotlenku metalu alkalicznego, ftp. Wodorotlenku sodu, a rozpuszczalnik, jak chlo- M roform lub eter etylowy. Wolna zasade wyodreb¬ nia sie nastepnie znanymi metodami.Materialy wyjsciowe wytwarza sie w sposób na¬ stepujacy* 2-benzylo-5-fenylo-l,2,3,4-czterowodora- -y-karboline otrzymuje sie w syntezie indoli we- *L dlUg Fischera z N,N-dwufenylohydrazyny i N-ben- zylopiperydonu-4. Wyjsciowe mono- lub dwufluoro- czterowodoro-y-karboliny o wzorze 7, w których co najmniej jeden sposród podstawników X, Y ozna~ cza atom fluoru, a Rf oznacza rodnik benzylowy, M otrzymuje sie z odpowiednich zwiazków o wzorze 7, w których fe2 oznacza atom wodoru, w reakcji z halogenkiem benzylu, jak bromek benzylu, uzy¬ tym w równomolowej ilosci. Zwiazki o wzorze l, w którym R£=H otrzymuje sie jak w opisie paten- 40 toWym St. Zjedn. Ameryki nr 4 0Ó1Z63.Ponizszy przyklad ilustruje sposób wedlug Wyna¬ lazku; P r a y k l a d. D,L-trans*8~fluoro^5-/p-£luoroferiy- 45 lo/-2y3,4,4a,5,9b*sz€s€Jiowodoro-lH-pirydo[4/3-b]ihdol.W szklanym riaczyriiu cisriieftlowyrii umi6szczsl sie 780 g &k palladu na Weglu, ilW hii Wódy, 18W,5 g (3,W mola) chlófOWOdóYkU fi,L-trafls^-ben- zylo-S-flUóffd^^/p^lttórdfehyló/^^^,^^,^ sa£s* 5o ciówodofÓ*lti-plryaó[4,3^b]indólU i 86,1 litra meta¬ nolu. Reaktor pf^plukujd sie azótem, nastepnik wodorem, po e*zyni wypeinia sie go Wodorem1 pód ciihieriteiri 84S.10* Pz i prowadzi reakcje uwócfór- riieriia W temtfefattirze 25—4l°C, w ciagu okolo 55 2 godzin. Reaktor c^ftfWieifza sie, przeplukuje' kio- tettt, po ttytfi rnieszarttrie reakcyjna przesacza *ie W celu Usurliecia katalizatora, fsatalizstóf przemy¬ wa Sle fneinn&stn, pó czytn pfZe^^Cz f popluczyny odparowuje sie #00 z^ririieiszdriynl cisriientóhi. fifó 80 pozostalosci dodaje sie 28 litrów chlorku metylenu i 87 iitfdw Wody, zawierajacej 852 g Wódófótlenku sddd. Otrzym^h^ friieszlaniri^ miesza sie. przez 10 rninut pr*y Wartosci jltt^lz i rozdziela WarstWy.Wsrstw^ wodna ekstrahuje si^ nastepna ptofcja 28 •f litrów chlorku metylenu, warstwy organiczne la-116 944 Czy sie i przemywa 26,5 1 wody. Wyciagi organicz¬ ne suszy sie nad bezwodnym siarczanem magnezu i zateza po dodaniu 95 1 heksanu. Otrzymana pap¬ ke oziebia sie do temperatury 8°C, saczy, przemy¬ wa heksanem i suszy. Otrzymuje sie 1446 g (wy¬ dajnosc 67%) produktu o temperaturze topnienia 115—118°C.Analiza elementarna: dla C17H16F2N2: Obliczono: C — 71,31, H — 5,63, N — 9,79, F — 13,27 Znaleziono: C — 71,25, H — 5,50, N — 9,76, F — 13,28.Widmo masowe M/e: 286 (100, m+) 257(50), 256(72), 243(61), 242(57), 148(32), 135(36), 57(79).Zastrzezenie patentowe Sposób wytwarzania nowych 4a,9b-trans-5-arylo- -2,3,4,4a,5,9b-szesciowodoro-lH-pirydo[4,3-b]indoli o wzorze 1, w którym X i Y oznaczaja atomy flu¬ oru, znamienny tym, ze na 4a,9b-trans-2,3,4,4a,9b- szesciowodoro-lH-pirydo[4,3-b]indol o wzorze 2, w którym X i Y maja wyzej podane znaczenie, a R2 oznacza rodnik benzylowy, dziala sie wodorem w obecnosci palladu na weglu. rxX7 Wzór 1 *XXXT! « -c- OH I ¦CH- Wzór i Wzór 5 '^CQHCH2,mCH-CH^y^ Y Wzór 2 ¦(CH2)n-MH0' 1 Wzór 6 N-R^ Wzór 7 Y Wzór 3116 944 9b.N R' N-(CH2)3CO-^y-F Wzór 8 X H k^N-Ra N- Yc H X Wzór 9 ~N-Rb N Wzór 10 Bltk 844/82 80 egz. A4 Cena 100 zl PL PL PL The subject of the invention is a method for preparing new 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido-[4,3-b]indoIi of formula 1, where X and Y are fluorine atoms, which are the starting compounds in the synthesis of new 4a,9ib-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H pyrido [4,3-b]indo!i (hexahydrogen-ro-y-carboline) and pharmaceutically acceptable salts of these compounds, which have a calming effect. After the introduction of reserpine and chlorpromazine into psychotherapy in the early 1950s, considerable effort was directed to the search for other treatments. calming agents with a better biological profile. Several active compounds have been found in the group of pyrido[4,3-b}indoles, called γ-carbolines. In the St. patent description United No. 3,687,961 discloses 8-fluoro-2-[3-/4-fluorophenylanilino/propyl]-1,2,3,4-tetrahydro-y-carboline as a useful sedative for warm-blooded animals. In the United States patent description No. 3,755,584, it was found that related compounds with fluorine atoms in positions 6 or 8 have similar activity, especially compounds substituted in position 2 with a phenylalkyl radical with a para substituent on the phenyl ring. In the patent description St. . United No. 3,983,239 describes hexahydrogen-y-carbolines of the formula 8, in which R1 is a methyl or ethyl radical and R2 is a hydrogen atom, a methyl radical or an ethyl radical. The description does not mention the stereochemical interdependence of hydrogen atoms bonded to carbon atoms in positions 4a and 9b. However, it can be expected that these atoms are in a cis position to each other, because the compounds were obtained by catalytic hydrogenation of the corresponding 1,2,3,4-tetrahydrogen-y-carbolines in the presence of platinum, and as is known, atoms hydrogen introduced in this way into the carbon-carbon double bond are in a mutual cis position. Compounds of formula 8 are claimed as neuroleptics, useful in the treatment of schizophrenia. In US Patent No. U 3 991 199 hexahydropyrido[4,3-b] indoles are presented, useful as analgesics and psychotropic agents. Some of them are interesting as sedatives, while others as agents releasing muscle tension. Many of them have hypotensive activity. in the described compounds, hydrogen atoms at the carbon atoms in positions 4a and 9b in the mutual trans position. The compounds are represented by the general formula 9, in which when Ya is -H, Xa is -H, -Cl, -Br, -CH3, -III .25 G4H9 or -OCH3, and when Ya=-OF3, then Xa=-H; and Ra represents a hydrogen atom or a 2-(3-chloro)butenyl, 2-bromoallyl, benzyl, benzyl radical substituted with a methyl radical, a methoxy group or a chlorine atom, phenylethyl, 3-phenylpropyl, 3-phenylpropyl, substituted 944116 644 3 in the ring with a chlorine or bromine atom or a methoxy group, furfuryl, 2-thienyl, C1-C8-alkyl, C8-C6-alkenyl, C8-C5-alkynyl, cinnamyl, cinnamyl substituted in the ring with a chlorine atom , bromine atom or methoxy group, 2-/3-phenyl/propynyl, C8-C7-cycloalkyl, C4-C8-cycloalkylmethyl, /methylcyclopropyl/methyl, /cis-2,3-dimethylcyclopropyl/methyl, C6-C7-cycloalkenylmethyl, C6-C8-cycloalkynylmethyl, [1-(2,3-dimethylcyclopropen-2/yl]-methyl exo-7-norkarylmethyl, [7-/cis-1j6-dimethyl-endb *3*noTkaTen7yl]methyl, 1-(4-methylbicyclo[2.2.2]octyl/rhetyl 1-(4-methylbicyclo]2.2.2[octen-2-yl)methyl, 5-(bicyclo[2.2. 2.1-repten-^-ylmethyl, 1-adamah*tylmethyl or 2-adamantylmethyl. In Belgian patent No. 845,368 (Derwent No. 00043Y) depicts 5-phenylsixhydrogen-y-carbolines, optionally substituted in the 2- and 4-positions by methyl or ethyl radicals, and in the 3-position by an alkyl radical with 1-3 carbon atoms, an allyl radical or a propargyl radical. These compounds are useful as antidepressants. German patent advertisement No. 2,631,836 (Derwent No. 0988Y) describes the structurally related octahydropyrido[4',3':2,3] indolo [1,7-ab] [l ]benzazepines, which can be represented by the formula 9, in which Ya is an ethyl bridge between two benzene rings, X* is a hydrogen atom, and Ra is a -CH2CH2COCH8 or -CH2CH2COC6H5 group. These compounds are useful as analgesics and sedatives. In Patent Specification 5t; United America No. 4,001 fttil, the calming 5*arylO*I,2M*e^terohydrofo*^carT3olin^ of the formula 1 is presented, which consists of a hydrogen or fluorine atom, and Rb is a methyl radical, a group, - CH^M-C^Z or */Gtt8/nl-CH=CH- -C6H4Z, in which formulas n is equal to 3 or 4, m jdst is equal to 2 or 3, M is -CO- or -CH/OH/-, and Z is hydrogen, fluorine or methoxy group, it has been found that it has a significantly higher antioxidant effect than l^^^-CKt^twater-o^- carbolines have trans-2,3,4,4a,5,9b-hexa- -lH- #ifydO[4,3-b]i*ldole with a general chip 3, in which gfujfc fflctoxy and pharmaceutically acceptable salts of these compounds or of the formula Ó, in which X and Y fflafó excluding the given meaning, m stands for HOZbe 2 Ittb 3, and z stands for a fluorine atom or gfupe methoxyl otphase, pharmaceutically acceptable salts of these compounds, in the mutual trans position there are hydrogen atoms in different compounds at the atom. It was found that compounds of the formula 3, in which X and thus limit your pits activity for at least 24 hours. The two bundles of formula I produced by the method according to the invention are the starting compounds for the production of compounds - WzófzG 3, which are unexpectedly active final compounds. The method according to the invention for the preparation of compounds of formula I, in which X and Y are the atoms of the fluid, is that the 4a,9b-trans-2,3,4, 4a,5,9b-hexas Odoro-1H-pyrido[4,3-b]-indole of the formula 2, in which X and Y are expressed given meaning, and R2 is a beniyl radical, is treated with hydrogen in the presence of palladium on WgglU. io The reactions are usually carried out on the hydrochloride of the compound of formula 2, at 50-100, preferably 00-75°C, under hydrogen pressure, 1.4-7 kG/cm2, in the presence of a solvent inert in the reaction, e.g. methanol, ethanol , isopropanol, ethyl acetate or mixtures of these solvents with water. After the hydrogen absorption is completed, the catalyst leaves the leaves and the compound of formula 1 is precipitated in the form of hydrohydride by adding e.g. ethyl ether, benzene or hexane. Alternatively, the compound of formula 1 can be isolated as the free base by evaporating the filtrate and debenzylation to dryness and partitioning the residue between an aqueous solution of alkali metal hydroxide, ftp. Sodium hydroxide and a solvent such as chloroform or ethyl ether. The free base is then isolated by known methods. The starting materials are prepared as follows: 2-benzyl-5-phenyl-1,2,3,4-tetrahydrogen-y-carboline is obtained in the synthesis of indoles in L dlUg Fischer from N,N-diphenylhydrazine and N-benzylpiperidone-4. The starting mono- or difluoro-tetrahydro-γ-carbolines of the formula 7, in which at least one of the substituents X, Y is a fluorine atom and Rf is a benzyl radical, M are obtained from the corresponding compounds of the formula 7, in which fe2 means a hydrogen atom reacted with a benzyl halide, such as benzyl bromide, used in an equimolar amount. Compounds of formula I, in which R£ = H, are obtained as described in the 40th St. patent. United Americas No. 4 0Ó1Z63. The following example illustrates the method of the Invention; EXAMPLE D,L-trans*8~fluoro^5-/p-fluoroferiyl-45/-2y3,4,4a,5,9b*s€Hiohydrogen-1H-pyrido[4/3- b]ihdol. In a glass cisrieftlowyrium there was 780 g of palladium on carbon, 18W.5 g (3.0 moles) of water, water, benzyl-S-flUoffd^^/p ^lttórdfehyló/^^^,^^,^ s^s* 5o ciówdofÓ*lti-plryaó[4,3^b]indólU and 86.1 liters of methanol. The reactor is flushed with nitrogen, then with hydrogen, then it is filled with hydrogen, then with 84S.10* Pz, and the reaction is carried out in a temperature of 25-4 l°C for about 2 hours. The reactor is heated, rinsed with kyotttt, after the reaction is filtered, in order to extract the catalyst, the catalytic converter is washed with water, the rinsing water is evaporated and evaporated. fifó 80 residues are added 28 liters of methylene chloride and 87 liters of water, containing 852 g of hydrophoxide sddd. Obtain ^h^ friieszlaniri^ mixed. for 10 minutes, the layers are separated and the water layer is extracted with 28 liters of methylene chloride, the organic layers are washed and washed with 26.5 liters of water. The organic extracts are dried over anhydrous magnesium sulfate and concentrated after adding 95 liters of hexane. The obtained slurry is cooled to 8°C, filtered, washed with hexane and dried. 1446 g (yield 67%) of product with a melting point of 115-118°C are obtained. Elemental analysis: for C17H16F2N2: Calculated: C - 71.31, H - 5.63, N - 9.79, F - 13 .27 Found: C - 71.25, H - 5.50, N - 9.76, F - 13.28. Mass spectrum M/e: 286 (100, m+) 257(50), 256(72), 243(61), 242(57), 148(32), 135(36), 57(79). Patent claim Method for producing new 4a,9b-trans-5-aryl-2,3,4,4a,5 ,9b-hexahydrogen-1H-pyrido[4,3-b]indole of the formula 1, in which X and Y are fluorine atoms, characterized in that at 4a,9b-trans-2,3,4,4a, 9b- hexahydrogen-1H-pyrido[4,3-b]indole of formula 2, in which X and Y have the meanings given above and R2 is a benzyl radical, is treated with hydrogen in the presence of palladium on carbon. rxX7 Pattern 1 *XXXT! « -c- OH I ¦CH- Formula and Formula 5 '^CQHCH2,mCH-CH^y^ Y Formula 2 ¦(CH2)n-MH0' 1 Formula 6 N-R^ Formula 7 Y Formula 3116 944 9b.N R' N -(CH2)3CO-^y-F Pattern 8 X H k^N-Ra N- Yc H X Pattern 9 ~N-Rb N Pattern 10 Bltk 844/82 80 copies A4 Price PLN 100 PL PL PL

Claims (1)

1. Zastrzezenie patentowe Sposób wytwarzania nowych 4a,9b-trans-5-arylo- -2,3,4,4a,5,9b-szesciowodoro-lH-pirydo[4,3-b]indoli o wzorze 1, w którym X i Y oznaczaja atomy flu¬ oru, znamienny tym, ze na 4a,9b-trans-2,3,4,4a,9b- szesciowodoro-lH-pirydo[4,3-b]indol o wzorze 2, w którym X i Y maja wyzej podane znaczenie, a R2 oznacza rodnik benzylowy, dziala sie wodorem w obecnosci palladu na weglu. rxX7 Wzór 1 *XXXT! « -c- OH I ¦CH- Wzór i Wzór 5 '^CQHCH2,mCH-CH^y^ Y Wzór 2 ¦(CH2)n-MH0' 1 Wzór 6 N-R^ Wzór 7 Y Wzór 3116 944 9b. N R' N-(CH2)3CO-^y-F Wzór 8 X H k^N-Ra N- Yc H X Wzór 9 ~N-Rb N Wzór 10 Bltk 844/82 80 egz. A4 Cena 100 zl PL PL PL1. Patent claim A method for preparing new 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles of formula 1, wherein and Y represent fluorine atoms, characterized in that 4a,9b-trans-2,3,4,4a,9b- hexahydrogen-1H-pyrido[4,3-b]indole of formula 2, in which X and Y have the meaning given above, and R2 is a benzyl radical, reacted with hydrogen in the presence of palladium on carbon. rxX7 Pattern 1 *XXXT! « -c- OH I ¦CH- Formula and Formula 5 '^CQHCH2,mCH-CH^y^ Y Formula 2 ¦(CH2)n-MH0' 1 Formula 6 N-R^ Formula 7 Y Formula 3116 944 9b. N R' N-(CH2)3CO-^y-F Pattern 8 X H k^N-Ra N- Yc H X Pattern 9 ~N-Rb N Pattern 10 Bltk 844/82 80 copies A4 Price PLN 100 PL PL PL
PL1978215923A 1977-05-23 1978-05-18 Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles,9b-geksagidro-1h-pirido/4,3-b/indolov PL116944B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79939277A 1977-05-23 1977-05-23

Publications (1)

Publication Number Publication Date
PL116944B1 true PL116944B1 (en) 1981-07-31

Family

ID=25175793

Family Applications (5)

Application Number Title Priority Date Filing Date
PL1978206903A PL114547B1 (en) 1977-05-23 1978-05-18 Process for preparing novel,substituted in position 2,4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles
PL1978215922A PL114541B1 (en) 1977-05-23 1978-05-18 Process for preparing novel,substituted in position 2,4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles
PL1978215923A PL116944B1 (en) 1977-05-23 1978-05-18 Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles,9b-geksagidro-1h-pirido/4,3-b/indolov
PL1978215921A PL117107B1 (en) 1977-05-23 1978-05-18 Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles-geksagirdid 1h-pirido 4,3-b ionidolov
PL20690379A PL206903A1 (en) 1977-05-23 1979-05-18 METHOD OF MANUFACTURING NEW SUBSTITUTED INDOLES IN POSITION 2-4A, 9B-TRANS-5-ARYL-2,3,4,4A, 5A, 9B-HIXHYDRO-1H-PYRIDO (4,3-B)

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL1978206903A PL114547B1 (en) 1977-05-23 1978-05-18 Process for preparing novel,substituted in position 2,4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles
PL1978215922A PL114541B1 (en) 1977-05-23 1978-05-18 Process for preparing novel,substituted in position 2,4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL1978215921A PL117107B1 (en) 1977-05-23 1978-05-18 Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles-geksagirdid 1h-pirido 4,3-b ionidolov
PL20690379A PL206903A1 (en) 1977-05-23 1979-05-18 METHOD OF MANUFACTURING NEW SUBSTITUTED INDOLES IN POSITION 2-4A, 9B-TRANS-5-ARYL-2,3,4,4A, 5A, 9B-HIXHYDRO-1H-PYRIDO (4,3-B)

Country Status (31)

Country Link
JP (1) JPS53144600A (en)
AR (2) AR217688A1 (en)
AT (1) AT368995B (en)
AU (1) AU499618B1 (en)
BE (1) BE867249A (en)
CA (1) CA1094071A (en)
CH (1) CH634321A5 (en)
CS (1) CS207612B2 (en)
DD (4) DD146186A5 (en)
DE (1) DE2822465C2 (en)
DK (1) DK226678A (en)
EG (1) EG13590A (en)
FI (1) FI63402C (en)
FR (1) FR2392023A1 (en)
GB (1) GB1586655A (en)
GR (1) GR69985B (en)
HU (3) HU185009B (en)
IE (1) IE46975B1 (en)
IL (1) IL54755A (en)
IT (1) IT1096307B (en)
LU (1) LU79684A1 (en)
NL (1) NL7804210A (en)
NO (2) NO150204C (en)
NZ (1) NZ187333A (en)
PH (1) PH13756A (en)
PL (5) PL114547B1 (en)
PT (1) PT68058B (en)
SE (2) SE441448B (en)
SU (4) SU873883A3 (en)
YU (4) YU91478A (en)
ZA (1) ZA782918B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
RU2106864C1 (en) * 1995-10-23 1998-03-20 Николай Серафимович Зефиров New approach to treatment of alzheimer's disease
SE9604786D0 (en) * 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
SE9904675D0 (en) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0101773D0 (en) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101770D0 (en) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (en) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (en) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205452A1 (en) * 1973-12-06 1976-05-07 Endo Lab METHOD TO PREPARE NEW TRANS-2, 3, 4, 4A, 5, 9B-HEXAHYDRO-5-PHENYL-1H-PYRID (4,3-B) INDOLES
JPS50126699A (en) * 1974-03-20 1975-10-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines

Also Published As

Publication number Publication date
SU818484A3 (en) 1981-03-30
DE2822465A1 (en) 1978-11-30
IL54755A0 (en) 1978-07-31
SE448459B (en) 1987-02-23
SE441448B (en) 1985-10-07
FI781612A (en) 1978-11-24
ZA782918B (en) 1979-06-27
PT68058B (en) 1979-10-24
NO150204B (en) 1984-05-28
HU185009B (en) 1984-11-28
DD145537A5 (en) 1980-12-17
DK226678A (en) 1978-11-24
CH634321A5 (en) 1983-01-31
SE8305917D0 (en) 1983-10-27
IE46975B1 (en) 1983-11-16
GB1586655A (en) 1981-03-25
BE867249A (en) 1978-11-20
DD146186A5 (en) 1981-01-28
AU499618B1 (en) 1979-04-26
YU221782A (en) 1983-01-21
EG13590A (en) 1982-03-31
AR217688A1 (en) 1980-04-15
FI63402C (en) 1983-06-10
PL114541B1 (en) 1981-02-28
SU843749A3 (en) 1981-06-30
DD138321A5 (en) 1979-10-24
PL117107B1 (en) 1981-07-31
ATA369678A (en) 1982-04-15
PL206903A1 (en) 1979-10-22
SE7803625L (en) 1978-11-24
NO151862B (en) 1985-03-11
JPS53144600A (en) 1978-12-15
NO150204C (en) 1984-09-05
NO831790L (en) 1978-11-24
HU188802B (en) 1986-05-28
IT7823673A0 (en) 1978-05-22
SU873883A3 (en) 1981-10-15
LU79684A1 (en) 1979-12-06
YU221682A (en) 1983-01-21
SU841589A3 (en) 1981-06-23
IT1096307B (en) 1985-08-26
IL54755A (en) 1981-02-27
PL114547B1 (en) 1981-02-28
NO151862C (en) 1985-06-19
CA1094071A (en) 1981-01-20
YU40796B (en) 1986-06-30
GR69985B (en) 1982-07-22
IE781013L (en) 1978-11-23
FR2392023B1 (en) 1980-11-07
JPS5711912B2 (en) 1982-03-08
AT368995B (en) 1982-11-25
SE8305917L (en) 1983-10-27
FI63402B (en) 1983-02-28
DD145536A5 (en) 1980-12-17
PT68058A (en) 1978-06-01
CS207612B2 (en) 1981-08-31
AR221721A1 (en) 1981-03-13
FR2392023A1 (en) 1978-12-22
NL7804210A (en) 1978-11-27
NZ187333A (en) 1984-05-31
NO781770L (en) 1978-11-24
HU187782B (en) 1986-02-28
YU91478A (en) 1983-01-21
PH13756A (en) 1980-09-17
YU221882A (en) 1983-01-21
DE2822465C2 (en) 1986-08-28

Similar Documents

Publication Publication Date Title
JP4231290B2 (en) Substituted pyridoindoles as agonists and antagonists of serotonin
EP1192165B1 (en) Substituted heterocycle fused gamma-carbolines
CA2432181C (en) Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
MXPA05002622A (en) Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders.
PL116944B1 (en) Process for preparing novel 4a,9b-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indoles,9b-geksagidro-1h-pirido/4,3-b/indolov
Charifson et al. Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1, 2, 3, 4-tetrahydroisoquinolines as dopamine receptor ligands
WO2004078721A1 (en) Processes for producing cyclic benzamidine derivative
AU684165B2 (en) New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them
RU2098415C1 (en) Method of synthesis of the substituted benzofuran derivatives or their pharmaceutically acceptable salts
EP1362854B1 (en) Benzo[b[thiophene derivatives and process for producing the same
Kuehne et al. Three routes to the critical C16'-C14'parf relative stereochemistry of vinblastine. Syntheses of 20'-desethyl-20'-deoxyvinblastine, and 20'-desethyl-20'-deoxyvincovaline
CS29991A2 (en) Tricyclo-cyclic amines, method of their preparation and pharmaceutical preparations that them contain
AU736710B2 (en) New indanol compounds, a process for their preparation and pharmaceutical compositions containing them
KR920003065B1 (en) Process for preparing benzodioxyno pyrrole derivatives
US5272143A (en) 6-oxoazepinoindole compounds, and pharmaceutical compositions containing them
Zumbrunn The first versatile synthesis of 1-alkyl-3-fluoro-1H-[1, 2, 4] triazoles
PL136930B1 (en) Method of obtaining novel derivatives of benzodiazepine
Cravotto et al. A library of pyranocoumarin derivatives via a one‐pot three‐component hetero diels‐alder reaction
Brown et al. Preparation of oxonanes and azonanes by oxidative ring expansion: synthesis of obtusan
US4996211A (en) Substituted dibenzocycloheptenimines
EP1423123A1 (en) Tetracyclic indole derivatives as 5-ht receptor ligands
He et al. A Versatile Total Synthesis of 8‐Oxyberberine and Oxohomoberberines
MXPA05002830A (en) Antidepressant piperidine derivatives of heterocycle-fused benzodioxans.
WO2021015109A1 (en) Method for producing phenol derivative
Savelli et al. Synthesis of 1H‐pyrazino [1, 2‐a] pyrido [2, 3‐e] pyrazine and 2H‐Pyrano [2, 3‐b] pyrido [2, 3‐e] pyrazine Derivatives